Table 1 Profile of study participants: demographic, clinical, and laboratory parameters

N

582

234

Age, y; median (IQR)

11 (7–14)

11 (7–15)

Females, n (%)

292 (50.1%)

119 (50.8%)

BMI, kg/m²; median (IQR)

19 (15.6–22.7)

18 (16.0–19.75)

Family history of HTN, n (%)

95 (19.8%)

39 (16.6%)

Family history of High cholesterol, n (%)

109 (18.7%)

26 (11.11%)

Family history of Heart Attack, n (%)

15 (2.57%)

5 (2.13%)

Family history of DM, n (%)

103 (17.6%)

30 (12.8%)

Family history of Obesity, n (%)

78 (13.4%)

26 (11.1%)

Family history of Smoking, n (%)

113 (19.4%)

45 (19.23%)

Consanguinity, n (%)

211 (37.9%)

39 (16.6%)

Traditional biomarkers

HbA1c%; (Ref 4.4–6.4)

5.24 (4.97–5.46)

5.22 (4.95–5.44)

Glucose, mmol/L; (Ref 3.9–6.1)

4.86 (4.49–5.36)

4.81 (4.47–5.28)

HsCRP; mg/L; (Ref < 5)

0.53 (0.21–1.6)

0.33 (0.16–0.65)

Total Cholesterol mmol/L; (Ref 3.1–5.6)

4.05 (3.6–4.5)

4.0 (3.60–4.5)

HDL mmol/L; (Ref 0.91–2.21)

1.39 (1.17–1.64)

1.48 (1.27–1.75)

LDL mmol/L; (Ref 2.6–3.3)

2.47 (2.08–2.9)

2.41 (2.06–2.82)

Triglycerides mmol/L; (Ref 0.4–2.1)

0.81 (0.61–1.17)

0.73 (0.59–1.0)